We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
American Financial (AFG) to Enhance Shareholders' Value
Read MoreHide Full Article
American Financial Group (AFG - Free Report) plans a special dividend of $12.00 to $14.00 per share, following the closing of the sale of its Annuity business to Massachusetts Mutual Life Insurance Company. If the special dividend is approved by the board of directors, it would be the 13th special dividend paid by this Zacks Rank #2 (Buy) property and casualty insurer in the last 10 years.
In January 2021, American Financial agreed to divest its Annuity business to Massachusetts Mutual. This will mark the company’s exit from the fixed and indexed annuity market. American Financial estimates to recognize an after-tax gain on the sale of $680 million to $700 million ($7.85 to $8.10 per share), when the sale closes in the second quarter of 2021. It expects to receive cash sale proceeds of $3.4 billion. Management noted this divestiture will considerably boost the insurer’s capital and liquidity.
American Financial has traditionally maintained moderate adjusted financial leverage around 20%, with good cash flow and interest coverage ratio. As of Mar 31, 2021 excess capital is approximately $1.2 billion, which includes parent company cash of approximately $200 million. It intends to hold back about $200–$300 million of the excess capital to maintain flexibility for any opportunity that may arise in the future.
Solid operating profitability at the P&C segment, a stellar investment performance and effective capital management boost shareholder return. In each of the last 14 years, the company has successfully increased its dividends apart from paying out special dividends and buying back shares. Its dividend yield of 1.5% betters the industry average of 0.4%.
Shares of American Financial have gained 48.4% year to date, outperforming the industry’s rise of 19.6%. The company’s superior underwriting discipline and sound capital structure should help it retain the momentum.
Among other insurers, RLI Corp. (RLI - Free Report) and Radian Group (RDN - Free Report) hiked its quarterly dividend by 4.1% and 12%, respectively. Last month, the board of directors of The Travelers Companies (TRV - Free Report) approved a 4% hike in its quarterly dividend.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better. See these 7 breakthrough stocks now>>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Shutterstock
American Financial (AFG) to Enhance Shareholders' Value
American Financial Group (AFG - Free Report) plans a special dividend of $12.00 to $14.00 per share, following the closing of the sale of its Annuity business to Massachusetts Mutual Life Insurance Company. If the special dividend is approved by the board of directors, it would be the 13th special dividend paid by this Zacks Rank #2 (Buy) property and casualty insurer in the last 10 years.
In January 2021, American Financial agreed to divest its Annuity business to Massachusetts Mutual. This will mark the company’s exit from the fixed and indexed annuity market. American Financial estimates to recognize an after-tax gain on the sale of $680 million to $700 million ($7.85 to $8.10 per share), when the sale closes in the second quarter of 2021. It expects to receive cash sale proceeds of $3.4 billion. Management noted this divestiture will considerably boost the insurer’s capital and liquidity.
American Financial has traditionally maintained moderate adjusted financial leverage around 20%, with good cash flow and interest coverage ratio. As of Mar 31, 2021 excess capital is approximately $1.2 billion, which includes parent company cash of approximately $200 million. It intends to hold back about $200–$300 million of the excess capital to maintain flexibility for any opportunity that may arise in the future.
Solid operating profitability at the P&C segment, a stellar investment performance and effective capital management boost shareholder return. In each of the last 14 years, the company has successfully increased its dividends apart from paying out special dividends and buying back shares. Its dividend yield of 1.5% betters the industry average of 0.4%.
Shares of American Financial have gained 48.4% year to date, outperforming the industry’s rise of 19.6%. The company’s superior underwriting discipline and sound capital structure should help it retain the momentum.
Among other insurers, RLI Corp. (RLI - Free Report) and Radian Group (RDN - Free Report) hiked its quarterly dividend by 4.1% and 12%, respectively. Last month, the board of directors of The Travelers Companies (TRV - Free Report) approved a 4% hike in its quarterly dividend.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>